Solarium’s 1.2GW factory and 60% pipeline conversion target

Solarium Green Energy Limited — H2 & FY26 Earnings Call (FY ended Mar 31, 2026)

1. Overall Tone of Management: Optimistic

• Management highlights multiple positives: “macro backdrop… broadly constructive,” “commissioning of our 1.2 gigawatt fully automated module manufacturing facility,” and “meaningful traction” in residential distribution.
• Confidence is explicit: “I am confident in the direction where we are headed.”
• Even when discussing margin pressure, they frame it as transitional: finance cost “only one-time setup” and expect stabilization as manufacturing ramps.

2. Key Themes from Management Commentary

• Vertical integration & manufacturing ramp-up
• Commissioned 1.2 GW automated module facility in Ahmedabad; running at ~45% utilization.
• Uses AI quality control + RFID traceability; positioned to meet evolving customer requirements.
• Captive consumption expected to rise to 50–60% in-house (EPC + kits + external EPC players).
• Strategic shift toward large EPC / ground-mounted
• Deliberate move to reduce exposure to extended receivable cycles in government-distributed programs.
• Trade-off acknowledged: lower gross margins but better cash conversion control.
• Integration thesis: EPC order book supports manufacturing utilization; manufacturing supports EPC scale.
• Residential growth via “Solar Kits” + Sarathi partner network
• Launched residential solar kits; Sarathi network scaled to 450+ partners across 25+ cities.
• Kit model designed to enable Solarium to sell to 20,000+ empaneled EPC players under PM Surya Ghar.
• ALMM-II (domestic content) handled as manageable
• Management argues a large portion of order book relates to bids before Aug 31, 2025, where non-domestic cells were permissible.
• They claim they are advanced in securing domestically manufactured cell for residential EPC/kits.
• Conclusion: “We do not see ALM M-II as an unmanageable constraint.”
• Financial performance framed as investment-phase
• Revenue up strongly (₹368 cr, +60% YoY) and EBITDA up (₹35.3 cr, +31% YoY).
• PAT growth is limited by higher finance cost and gross margin compression tied to EPC mix and working capital build.

3. Q&A Analysis

Theme A: Manufacturing facility utilization, capacity economics, and sales vs captive split

• Core questions
• Current utilization and timeline to “optimal”
• Whether capacity is captive-only or includes external sales
• Breakup of external vs captive consumption
• Management response
• Utilization: ~45%, temporarily reduced due to ALMM2 applicability.
• Captive consumption expectation: 40–50% in-house for EPC; plus kits as another major consumer; targeting 50–60% in-house consumption overall.
• External sales: acknowledged via orders from other EPC players; also stated an external module order book of ₹35–40 cr with month-on-month delivery over next couple of months.
• Notable / partial / evasive elements
• “Optimal utilization” and “optimal” revenue were asked, but management did not give a clear quantitative “optimal utilization” target in FY27 in this call (unlike prior call where utilization targets were more explicit).

Theme B: EPC concentration risk and pipeline conversion

• Core questions
• Concentration risk (e.g., one large Maharashtra project)
• Conversion rate from pipeline/discussions to confirmed orders and timeframe
• Management response
• Concentration risk acknowledged, but they emphasize execution complexity even in non-concentrated sites (“every site has their own decision maker”).
• Pipeline conversion: conversion rate “very difficult to say” due to deal-size skew; however, they are “hopeful… within next 2–3 months, at least 60% of conversion” from the pipeline.
• Notable / unusually strong answer
• The “60% conversion within 2–3 months” is fairly assertive given they simultaneously say conversion is hard to quantify.

Theme C: Margin outlook, EBITDA normalization, and manufacturing margin assumptions

• Core questions
• Is ~9.5% EBITDA / ~30% gross margin the new normal?
• Pathway back to higher margins as integration deepens
• Manufacturing margins and cost-plus model assumptions
• Management response
• EBITDA margin expectation: “10% to 12%” (asked as a range; management agreed).
• Gross margin recovery: framed as improving as manufacturing integration reduces external procurement dependency.
• Manufacturing margin: “cost-plus model” and target overall margins above ~15%; also said domestic procurement may not reduce margins because industry passes through cost changes.
• Notable / partial elements
• They did not provide a clean bridge from FY26 gross margin ~30% to FY27 exit with segment-level reconciliation; answers stayed at directional/range level.

Theme D: Debt, interest cost normalization, and working capital dynamics

• Core questions
• Current debt and repayment schedule
• Whether interest costs normalize in FY27
• Receivables cycle going forward under ground-mounted EPC
• Management response
• Interest cost: FY26 finance cost ₹10.5 cr; majority tied to working capital for manufacturing; term loan ~₹50 cr repayable over 6 years.
• Repayment: working capital loans are overdraft/repayable on demand; term loan amortizes over years.
• Working capital cycle improvement: for ground-mounted EPC, cash is received during execution and within 15–30 days after module delivery; overall working capital for a ~₹150 cr project expected < ₹30–35 cr (vs ~120–150 days in some government projects).
• Notable / unusually strong clarity
• The working capital cycle reduction is quantified and specific, which is a positive credibility signal.

Theme E: Residential kit economics, run-rate, and execution timeline

• Core questions
• Actual captive consumption vs target
• Residential monthly run-rate and end-of-year expectations
• Execution timing for module orders and order book breakdown
• Management response
• Captive consumption: since production started mid-March, whatever produced was utilized in distribution sales.
• Residential run-rate: ₹10–12 cr/month (excluding solar kit); with kit, expected ₹16–18 cr by end of year.
• Order book execution: almost 100% executed within this year; mix across H1/H2 but majority within the year.
• Notable / partial elements
• “Monthly run-rate” is given, but not tied to margin impact or customer acquisition costs.

4. Guidance / Outlook

Explicit guidance (quantitative)

• FY27 EBITDA margin: management indicated “10% to 12%” (and agreed to the question that FY27 exit EBITDA margins can be around that range).
• FY27 revenue growth (directional): “revenue continue to grow more at whatever rate it has grown in the past couple of years” (no numeric target).
• Margins: “minimally protected at this level” and “no further fall” expected; manufacturing integration should support recovery.
• CAPEX: “not foreseeing any major CAPEX during this year” (FY27).
• Finance cost normalization: interest cost expected to reduce as manufacturing ramps; however, no absolute FY27 interest expense number was provided beyond clarifying it won’t jump to ₹30–35 cr.

Implicit signals (qualitative)

• Manufacturing ramp is central to the FY27 story: finance cost as % of revenue should decline as returns start.
• ALMM-II is treated as a near-term operational constraint (utilization reduced for ~10 days), but not a structural threat.
• EPC execution is expected to remain strong given order book and pipeline conversion expectations.

5. Standout Statements (direct / high-signal)

• Manufacturing utilization & ALMM impact
• “Currently, the factory is running at around 45% utilization. We have reduced the utilization for last 10 days because of this ALMM2 applicability.”
• Captive consumption target
• “We are expecting almost 40% to 50%… captively consumed” and “targeting 50% to 60% in-house consumption.”
• EPC working capital rationale
• Ground-mounted EPC chosen to “reduce our exposure to the extended receivable cycles” and improve cash conversion control.
• Finance cost framing
• Finance cost increase is “only one-time setup” and should stabilize as manufacturing ramps.
• FY27 margin guidance
• “We expect margins to be minimally protected at this level…” and EBITDA margin “10% to 12%.”
• Pipeline conversion confidence
• “within next 2–3 months, at least 60% of conversion” from the active pipeline.

6. Red Flags / Positive Signals

Red flags
– Utilization “45%” with ALMM2 causing operational pause suggests ramp may be less smooth than implied.
– Conversion certainty: “60% conversion in 2–3 months” conflicts with earlier admission that conversion rates are “very difficult to say.”
– Margin bridge remains vague: they provide ranges but limited segment-level reconciliation from FY26 gross margin compression to FY27 exit.

Positive signals
– Clear working capital improvement mechanism for ground-mounted EPC (15–30 day collections after module/BOS delivery).
– Concrete operational metrics: utilization, captive split targets, residential monthly run-rate, external module order book and delivery cadence.
– No major FY27 CAPEX reduces execution risk and cash burn risk.

7. Historical Comparison & Consistency Analysis (vs prior calls)

a. Change in Tone Over Time

• Current call (FY26 full year): more “investment-phase” realism—acknowledges margin compression and higher finance costs, but remains confident about stabilization.
• Prior call (H1 FY26, Nov 2025): more optimistic on growth and margin expansion; also explicitly guided commissioning timeline and utilization ramp.
• Classification: More Cautious (not pessimistic), because FY26 results show gross margin moderation and PAT only marginally up, whereas H1 FY26 emphasized strong margin expansion and confidence.

b. Tracking Past Commitments vs Outcomes

1) Module plant commissioning timeline
– Past statement (H1 FY26 call): module manufacturing “commissioned by mid-January” (and operational by end of Jan).
– What happened (current call): facility commissioned; production started mid-March (March 14/15) and utilization is ~45%.
– Assessment: ✅ Delivered on commissioning, but ⏳ ramp/production start slipped vs “mid-January” expectation.

2) Utilization ramp to 75–80%
– Past statement (H1 FY26 call): target utilization 75–80%, with internal target “75% within first quarter FY 2027.”
– What happened (current call): current utilization ~45% (and only recently reduced due to ALMM2).
– Assessment: ⏳ Delayed / not yet achieved (at least by FY26 year-end).

3) Finance cost normalization
– Past statement (H1 FY26 call): finance cost elevated due to working capital delays; expected to normalize (Q4 onwards).
– What happened (current call): FY26 finance cost is ₹10.5 cr vs ₹3.5 cr in FY25; management now says it’s a setup cost tied to CAPEX + working capital and should stabilize as manufacturing ramps.
– Assessment: ⏳ Not yet normalized; explanation shifted from “receivable delays” to “manufacturing CAPEX/working capital setup.”

c. Narrative Shifts

• From “residential + government execution” to “EPC cash conversion + manufacturing integration”
• H1 FY26 emphasized residential franchise expansion and government order visibility.
• FY26 full-year call emphasizes ground-mounted EPC as a deliberate cash conversion strategy and manufacturing utilization as the core enabler.
• ALMM-II handling becomes more prominent
• H1 FY26 discussed DCR/non-DCR capability and technology readiness.
• FY26 call explicitly ties ALMM2 to utilization reduction and order book composition.

d. Consistency & Credibility Signals

• Medium credibility
• Positives: operational explanations are detailed (working capital cycle mechanics, debt split, captive consumption logic).
• Concerns: some targets/ramp expectations (utilization) appear behind schedule; pipeline conversion confidence is high despite acknowledging conversion uncertainty.

e. Evolution of Key Themes

• Demand/macro: consistently constructive (government targets, PM Surya Ghar momentum).
• Margins: deteriorated vs earlier optimism—FY26 gross margin fell to ~30% (EPC mix + lower margins), with FY27 framed as recovery to 10–12% EBITDA.
• Cash conversion / working capital: strengthened narrative—shift to ground-mounted EPC to reduce receivable cycle risk.
• Integration: moved from “backward integration milestone” (H1) to “self-reinforcing EPC-manufacturing model” (FY26).

f. Additional Insights (cross-period intelligence)

• The company’s core risk has quietly shifted:
• H1 FY26: receivable delays (defense-linked) were the main driver of elevated finance cost.
• FY26: elevated finance cost is now largely attributed to manufacturing CAPEX + working capital, implying a structural near-term drag until ramp returns.
• ALMM2 is now operationally material (utilization reduced), suggesting regulatory transitions may affect ramp more than previously implied.